Advertisement
Screener

Asensus Surgical, Inc. Forms 3, 4 and 5: Stock Options, 2023

Asensus Surgical, Inc. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2023-06-06: Reporting owner Hobert Kevin J; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2023-06-06: Reporting owner Milne David Bruce; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2023-06-06: Reporting owner Biffi Andrea; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2023-06-06: Reporting owner Starling William N JR; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2023-06-06Hobert Kevin J
Director
4Stock Option
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+55,748
55,748 owned after
$0.56
exercise price
2023-06-08
2023-06-06Milne David Bruce
Director
4Stock Option
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+55,748
55,748 owned after
$0.56
exercise price
2023-06-08
2023-06-06Biffi Andrea
Director
4Stock Option
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+117,690
117,690 owned after
$0.56
exercise price
2023-06-08
2023-06-06Starling William N JR
Director
4Stock Option
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+55,748
55,748 owned after
$0.56
exercise price
2023-06-08
2023-02-03Shameze Rampertab
Officer (EVP, Chief Financial Officer)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+175,000
175,000 owned after
$0.75
exercise price
2023-02-07
2023-02-03Fernando Anthony C. J.
Director, Officer (President and CEO)
4Stock Options
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+375,000
375,000 owned after
$0.75
exercise price
2023-02-07